Bank of Nova Scotia receives Fed approval for MapleMark acquisition: BNS remains under pressure

Bank of Nova Scotia receives Fed approval for MapleMark acquisition: BNS remains under pressure
Bank of Nova Scotia up 0.35% today

Bank of Nova Scotia (BNS) stock is trading at C$131.47 with a modest gain on the day. The price remains below its short- and medium-term moving averages, but is still positioned above its long-term trend support.

BNS price prediction
24H 0.13%
CA$132.02
48H 0.2%
CA$132.11
7D 0.25%
CA$132.18
1M 1.97%
CA$134.45
3M 13.07%
CA$149.08
6M 7.55%
CA$141.8
12M 42.44%
CA$187.81
Current price: CA$131.85 -0.3700 0.28%
Closed 11/13
Daily range 131.25 Arrow from to Icon 132.69
Weekly range 130.64 Arrow from to Icon 133.30
Loading...

Highlights

  • Bank of Nova Scotia received Federal Reserve approval to acquire MapleMark Bank, granting direct entry into the US commercial banking segment.
  • This acquisition extends geographic reach and may diversify Bank of Nova Scotia's loan portfolio with new US lending segments.
  • Shares of Bank of Nova Scotia trade under short-term selling pressure with an expected C$129.58 to C$133.36 range in the next two to three days.

US market entry advances as Fed approves MapleMark acquisition

The most notable recent development for Bank of Nova Scotia is the approval from the Federal Reserve for its acquisition of Maple Financial Holdings, Inc. and its state member bank subsidiary, MapleMark Bank, as reported by Ritzherald. This regulatory green light provides direct access to the US commercial banking market, expanding the bank's geographic reach and potentially diversifying its loan book. Such cross-border acquisitions can enhance revenue streams and align with long-term strategic objectives, especially as US market entry often unlocks new customer and lending segments.

Bank of Nova Scotia asset chart
Bank of Nova Scotia price dynamics. Source: TradingView.

Intraday momentum weakens as sellers control below resistance

On the hourly timeframe, BNS trades below both its MA-20 at C$132.3 and MA-50 at C$131.51, while remaining well above the daily MA-200 at C$114.39. The Ichimoku Kijun sits at C$132.33, now acting as immediate resistance. Momentum indicators reinforce a cautious view: MACD is neutral, ADX signals a sell bias, and the Awesome Oscillator confirms the negative trend. RSI is at 43.61, pointing to oversold conditions, with CCI and Bull/Bear Power both aligning on a sell signal. Stochastic RSI is neutral. Overall, sellers dominate intraday momentum and volatility remains moderate.

Mild downside favored as volatility bands define near-term action

Over the next two to three trading days, BNS is expected to fluctuate within a typical volatility band between C$129.58 and C$133.36. Current scenario probabilities favor a mild bearish tilt, with a 53% chance of downside versus a 47% likelihood of an upward move. A decisive break above resistance at C$132.33 would open the door to a bullish extension, while a close below C$129.58 could accelerate declines and shift sentiment more firmly negative.

Anton Kharitonov, expert at Traders Union, sees Bank of Nova Scotia gaining a regulatory edge with U.S. market entry, but the technical backdrop remains weak. He notes that most intraday momentum indicators signal caution, and sellers dominate below key resistance at C$132.33. Base case remains for further consolidation or mild downside unless a clear break above resistance occurs. "Until BNS closes decisively above C$132.33, I remain defensive and see limited upside for now."

Earlier, analysts noted that Bank of Nova Scotia maintained a broadly bullish structure, supported by resilient fundamentals and ongoing stability in earnings and capital management. The recent approval of its US acquisition adds a new strategic dimension, and traders should monitor the C$132.33 resistance as a potential inflection point for near-term direction.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.